Researchers explore stem cell therapy for amyotrophic lateral sclerosis

06/19/2014 | Healio (free registration)

Mayo Clinic researchers will conduct an early-stage clinical trial of the use of stem cells to stop the progression of amyotrophic lateral sclerosis. Autologous modified fat-derived mesenchymal stem cells will be infused through a spinal tap to promote nerve cell survival.

View Full Article in:

Healio (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN